The scientific services company expands its portfolio to include expertise in oncology clinical studies.
The test seeks to identify patients with metastatic pancreatic cancer and high levels of hyaluronan.
MM+M Transform: The Patient, Provider and Payer Engagement Matrix provides the most in-depth look at the marketing and technology trends likely to influence the industry’s growth over the next year.
Get the most out of
Register for free and enjoy unlimited access to: